Addition of More Immunosuppressive Drugs As Graft-Versus-Host Disease (GVHD) Prophylaxis Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors

被引：1
|
作者：
Michallet, Mauricette [1 ]
Sobh, Mohamad [1 ]
Barraco, Fiorenza [1 ]
Thomas, Xavier [1 ]
Balsat, Marie [1 ]
Lejeune, Caroline [1 ]
Ducastelle, Sophie [1 ]
Renault, Myriam [1 ]
Tedone, Nathalie [1 ]
Labussiere, Helene [1 ]
Nicolini, Franck-Emmanuel [2 ]
机构：
[1] Ctr Hosp Lyon Sud, Dept Hematol 1G, Pierre Benite, France
[2] Ctr Hosp Lyon Sud, Hematol Clin 1G, Pierre Benite, France
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5786.5786
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5786
引用
收藏
页数：5
相关论文
共 50 条
  • [1] SIROLIMUS IN COMBINATION WITH CYCLOSPORINE OR TACROLIMUS PLUS METHOTREXATE FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS AFTER HEMATOPOIETIC CELL TRANSPLANTATION FROM UNRELATED DONORS
    Furlong, T.
    H.-P, Kiem
    Appelbaum, F. R.
    Carpenter, P. A.
    Deeg, J.
    Doney, K.
    Flowers, M. E. D.
    Mielcarek, M.
    Nash, R. A.
    Storh, R.
    Martin, P. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 140 - 141
  • [2] Addition of Mycophenolate Mofetil to Methotrexate and Tacrolimus Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation
    Han, Se Young
    Bhamidipati, Pavan Kumar
    Vu, Khoan
    Dipersio, John F.
    Gao, Feng
    Pusic, Iskra
    Uy, Geoffrey L.
    Westerveit, Peter
    Vij, Ravi
    Schroeder, Mark A.
    Abboud, Camille N.
    Stockerl-Goldstein, Keith
    Cashen, Amanda F.
    Fehniger, Todd A.
    Romee, Rizwan
    BLOOD, 2015, 126 (23)
  • [3] PROPHYLAXIS AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE (GVHD) WITH DRUGS
    DEEG, HJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 209 - 209
  • [4] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    C Kasper
    H G Sayer
    L O Mügge
    K Schilling
    S Scholl
    M C Issa
    K Höffken
    Bone Marrow Transplantation, 2004, 33 : 65 - 69
  • [5] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    Kasper, C
    Sayer, HG
    Mügge, LO
    Schilling, K
    Scholl, S
    Issa, MC
    Höffken, K
    BONE MARROW TRANSPLANTATION, 2004, 33 (01) : 65 - 69
  • [6] Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL
    Nash, RA
    Storb, R
    CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (05) : 674 - 680
  • [7] Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation
    Inamoto, Yoshihiro
    Storer, Barry
    Petersdorf, Effie W.
    Carpenter, Paul A.
    Lee, Stephanie J.
    Nelson, Lee
    Sandmaier, Brenda M.
    Martin, Paul J.
    Flowers, Mary E. D.
    BLOOD, 2011, 118 (21) : 150 - 151
  • [8] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic stem cell transplantation
    Kasper, C
    Mügge, L
    Schilling, K
    Scholl, S
    Wollina, K
    Höffken, K
    Sayer, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S187 - S188
  • [9] Reduced-intensity conditioning allogeneic transplantation from unrelated donors:: Evaluation of mycophenolate mofetil plus cyclosporin a as graft-versus-host disease prophylaxis
    Perez-Simon, Jose A.
    Martino, Rodrigo
    Caballero, Dolores
    Valcarcel, David
    Rebollo, Noemi
    de la Camara, Rafael
    Perez de Oteiza, Javier
    Heras, Inmaculada
    Calvo, Maria V.
    Sierra, Jordi
    San Miguel, Jesus F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) : 664 - 671
  • [10] USE OR RITUXIMAB IN ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) POST ALLOGENEIC HEMATOPOIETIC CELL-TRANSPLANTATION
    Patel, S.
    Cavenagh, J.
    Gribben, J.
    De Vos, J.
    HAEMATOLOGICA, 2012, 97 : 726 - 727
12345